News

In the study, BioLineRx expects to investigate the safety, phamacokinetics and tolerability of BL-1021 in healthy volunteers. The primary endpoints of the study are to assess the safety

Talactoferrin has demonstrated activity in randomized, double-blind, placebo-controlled Phase II studies in non-small cell lung cancer (NSCLC) and in severe sepsis. The study has met the primary endpoint

The company already exports the drug to West Africa, South East Asia and Middle East markets. Marck has obtained approvals for the product in Benin, Kenya, Yemen, Nigeria,

Vij worked as Group President -Defence in Punj Lloyd. Before joining Punj Lloyd, Vij has worked with General Motors for 18 years and has held key leadership positions

LIOVEL is a combined fixed dose tablet of NESINA and ACTOS. NESINA (alogliptin) and Actos (pioglitazone Hcl) are indicated for a treatment of type 2 diabetes. LIOVEL is

As per the terms of the agreement, OctoPlus will act as a process development and manufacturing partner for microsphere-based formulation for the Danish pharma firm. OctoPlus is a

Most recently, Zerhouni was serving as the acting president and CEO of the Diamyd Medical since April 201, though he has been involved in all aspects of the

The study namely BOLERO-2 (Breast cancer trials of OraL EveROlimus-2) involved around 700 patients at over 195 sites worldwide. The study included postmenopausal women with ER+HER2- metastatic breast

A wholly subsidiary of Fresenius Kabi Pharmaceuticals, APP Pharma expects to launch extended product line of its current portfolio in next few months. The company will market Levothyroxine